Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 2012

View Archived Issues

TMX-202 shows potential as intravesically administered bladder cancer therapy

Orteronel investigated in nonmetastatic prostate cancer

Updated results presented from the AXIS trial

New VCP inhibitors designed in Japan

Novel metabotropic glutamate mGlu2 receptor antagonists patented

Prous Institute for Biomedical Research reports new multitargeted products

Eli Lilly presents novel products with potential to treat cancer

New 11-beta-HSD1 inhibitors developed at High Point Pharmaceuticals

Auriga identifies novel potential therapeutics for photodermatosis

Selective serotonin transporter radioligand investigated in healthy subjects and patients

Sirona Biochem assesses lead product in model of diabetes

Novartis seeks Afinitor line extensions in Japan

EMA accepts Takeda's MAA for peginesatide

Angiochem and GSK launch new collaboration

Eisai offers overview of third quarter of fiscal 2011

Neuronex enters merger agreement

CSL Behring screens first patient in global rVIII-SingleChain study

European Commission approves Glivec label update

Chinese institute divulges new beta-secretase 1 inhibitors

Esmya approved in Europe

Scripps Research Institute receives funds to develop new HIV inhibitors

Sanofi discloses new platelet adhesion-inhibiting peptides

Galen acquires chemotherapy agent from Gilead

FDA approves protocol amendment to ARISER study

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...